Adam Young

633 total citations
24 papers, 469 citations indexed

About

Adam Young is a scholar working on Rheumatology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adam Young has authored 24 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 10 papers in Hematology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adam Young's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Adam Young is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Adam Young collaborates with scholars based in United Kingdom, United States and Australia. Adam Young's co-authors include Désirée van der Heijde, Patrick Kiely, David A. Walsh, Daniel F. McWilliams, Emma Simpson, Matt Stevenson, Allan Wailoo, David L. Scott, Emma Everson-Hock and Weiya Zhang and has published in prestigious journals such as European Heart Journal, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Adam Young

23 papers receiving 451 citations

Peers

Adam Young
Moetaza M. Soliman Egypt
J. M. W. Hazes Netherlands
E. Nikaï United States
Radu Vasilescu Belgium
Thomas Langenegger Switzerland
Sofia Pazmiño Belgium
B Svensson Sweden
Timothy Shaver United States
Johan K. Wallman Sweden
Vernon F. Schabert United States
Moetaza M. Soliman Egypt
Adam Young
Citations per year, relative to Adam Young Adam Young (= 1×) peers Moetaza M. Soliman

Countries citing papers authored by Adam Young

Since Specialization
Citations

This map shows the geographic impact of Adam Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Young more than expected).

Fields of papers citing papers by Adam Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Young. The network helps show where Adam Young may publish in the future.

Co-authorship network of co-authors of Adam Young

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Young. A scholar is included among the top collaborators of Adam Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Young. Adam Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franke, Kyle B., Kelly A. Loffler, Stephen J. Nicholls, et al.. (2020). Effects of CPAP treatment on cardiac structure and function in individuals with obstructive sleep apnea and cardiovascular disease: a prospective 6-month randomised control trial. European Heart Journal. 41(Supplement_2). 1 indexed citations
2.
Bermejo, Iñigo, Shijie Ren, Emma Simpson, et al.. (2018). Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 36(12). 1427–1437. 3 indexed citations
3.
Stevenson, Matt, Allan Wailoo, Jonathan Tosh, et al.. (2017). The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate. The Journal of Rheumatology. 44(7). 973–980. 16 indexed citations
4.
Bermejo, Iñigo, Matt Stevenson, Rachel Archer, et al.. (2017). Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 35(11). 1141–1151. 2 indexed citations
5.
McWilliams, Daniel F., Eamonn Ferguson, Adam Young, Patrick Kiely, & David A. Walsh. (2016). Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data. Arthritis Research & Therapy. 18(1). 295–295. 25 indexed citations
6.
7.
Kelly, Clive, Adam Young, Yasmeen Ahmad, et al.. (2016). 092 The Effect of Steroids, Azathioprine and Mycophenolate on the Risk of Death in Rheumatoid Lung Disease. Lara D. Veeken. 5 indexed citations
8.
McWilliams, Daniel F., Michelle Marshall, Sally Doherty, et al.. (2016). Erosive and osteoarthritic structural progression in early rheumatoid arthritis. Lara D. Veeken. 55(8). 1477–1488. 16 indexed citations
9.
10.
Nikiphorou, Elena, Charlotte Davies, Miranda Mugford, et al.. (2015). Direct Health Costs of Inflammatory Polyarthritis 10 Years after Disease Onset: Results from the Norfolk Arthritis Register. The Journal of Rheumatology. 42(5). 794–798. 5 indexed citations
11.
Nikiphorou, Elena, Stephen Morris, J. Dixey, et al.. (2015). The Effect of Disease Severity and Comorbidity on Length of Stay for Orthopedic Surgery in Rheumatoid Arthritis: Results from 2 UK Inception Cohorts, 1986–2012. The Journal of Rheumatology. 42(5). 778–785. 7 indexed citations
12.
13.
McWilliams, Daniel F., Patrick Kiely, Adam Young, & David A. Walsh. (2013). Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort. BMC Musculoskeletal Disorders. 14(1). 153–153. 11 indexed citations
14.
Carpenter, Lewis, Elena Nikiphorou, & Adam Young. (2013). Importance of registries in informing clinical practice for arthritis. Clinical Practice. 10(6). 723–736. 3 indexed citations
15.
Norton, Sam, Amanda Sacker, J. Dixey, et al.. (2013). Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality. Lara D. Veeken. 52(11). 2016–2024. 46 indexed citations
16.
Young, Adam, et al.. (2013). Mohs micrographic surgery in the setting of squamoid eccrine ductal carcinoma: addressing a diagnostic and therapeutic challenge.. PubMed. 6(4). 33–6. 10 indexed citations
17.
McWilliams, Daniel F., et al.. (2012). Predictors of change in bodily pain in early rheumatoid arthritis: An inception cohort study. Arthritis Care & Research. 64(10). 1505–1513. 75 indexed citations
18.
Young, Adam, et al.. (2009). Why health matters for economic performance. RePEc: Research Papers in Economics. 57–72. 7 indexed citations
19.
Bansback, Nick, Adam Young, Alan Brennan, & J. Dixey. (2006). A prognostic model for functional outcome in early rheumatoid arthritis.. PubMed. 33(8). 1503–10. 21 indexed citations
20.
Young, Adam & Désirée van der Heijde. (1997). 2 Can we predict aggressive disease?. Baillière s Clinical Rheumatology. 11(1). 27–48. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moetaza M. Soliman Breakdown of academic impact, for papers by J. M. W. Hazes Breakdown of academic impact, for papers by E. Nikaï Breakdown of academic impact, for papers by Radu Vasilescu Breakdown of academic impact, for papers by Thomas Langenegger Breakdown of academic impact, for papers by Sofia Pazmiño Breakdown of academic impact, for papers by B Svensson Breakdown of academic impact, for papers by Timothy Shaver Breakdown of academic impact, for papers by Johan K. Wallman Breakdown of academic impact, for papers by Vernon F. Schabert
Rankless by CCL
2026